Takeda Pharma ADR Earnings miss, Revenue beats In Q3

  • Investing.com
Takeda Pharma ADR Earnings miss, Revenue beats In Q3

Investing.com - Takeda Pharma ADR reported third quarter earnings that missed analysts' expectations on Thursday and revenue that topped forecasts.

The firm reported earnings per share of ¥-0.048 on revenue of ¥7.43B. Analysts polled by Investing.com anticipated EPS of ¥0.232 on revenue of ¥7.4B. .

Takeda Pharma ADR shares gained 2.17% to trade at ¥14.12 in pre-market trade following the report.

Takeda Pharma ADR follows other major Healthcare sector earnings this month


On Thursday, Merck&Co reported third quarter EPS of ¥1.75 on revenue of ¥13.15B, compared to forecasts of EPS of ¥1.54 on revenue of ¥12.26B.

Hoya Corp earnings beat analyst's expectations on Thursday, with third quarter EPS of ¥1.02 on revenue of ¥1.43B. Investing.com analysts expected EPS of ¥0.9772 on revenue of ¥1.42B

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar

Drop an image here or Supported formats: *.jpg, *.png, *.gif up to 5mb

Error: File type not supported

Drop an image here or

100